Cognitive Function and Addiction Under Opioid Tapering
CompletedPhase 3NCT03365817
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the effects of opioid dose reduction in the treatment of chronic pain in adults. Participants were divided in two groups: 1) patients that reduced opioid dose and 2) patients that kept the same opioid dose for six months.
Study details
- Official title
- Cognitive Function and Addiction in Patients With Chronic Pain Under Opioid Tapering in a Multidisciplinary Pain Treatment
- Conditions
- Interventions
- Drug: Opioids taper off
- Drug: Opioid stable treatment
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
- Collaborators
- The Ministry of Science, Technology and Innovation, Denmark; Hørslev-Fonden
- Start date
- 2009-02-02
- Primary completion
- 2014-12-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age 18 years old or more * at least seven years of schooling * pain duration of at least six months, * treatment with oral opioids for more than three months * daily opioid dose ≥ 60 mg of oral morphine equivalent Exclusion Criteria: * not fluent in Danish language * cancer disease * poor general health condition * pregnancy, dementia * encephalopathy * brain damage * cranial base trauma * enrolled in other studies
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03365817